RPL18

Large ribosomal subunit protein eL18 · Q07020 · RPL18 on Sugi Atlas →

0 patent compounds predicted against RPL18, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL18 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES PHASE3UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) PHASE1/PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery PHASE1COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment PHASE1COMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma nanUNKNOWN
CCM Italian Registry nanUNKNOWN
Generating Intervals of Reference FFor Early Life Brain Biomarkers. nanRECRUITING
Modulation of Steroid Immunosuppression by Alveolar Efferocytosis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RPL18 binder may also engage these)

ProteinNameSimilarity
D0VWQ3 1.000 D0VWQ3 →
Q95342 1.000 Q95342 →
Q4R5H8 1.000 Q4R5H8 →
Q5E973 0.999 Q5E973 →
P12001 0.995 P12001 →
P35980 0.993 P35980 →
P69090 0.981 P69090 →
G1TFE0 0.980 G1TFE0 →
P69091 0.975 P69091 →
P02412 0.968 P02412 →
P09897 0.956 P09897 →
Q90YV0 0.955 Q90YV0 →
P17702 0.954 P17702 →
RPL28 Large ribosomal subunit protein eL28 0.953 landscape →
G1U7L1 0.953 G1U7L1 →
Q7ZV96 0.948 Q7ZV96 →
P41105 0.947 P41105 →
RPL11 Large ribosomal subunit protein uL5 0.943 landscape →
Q3T087 0.943 Q3T087 →
Q3T0L7 0.942 Q3T0L7 →
Q08200 0.942 Q08200 →
G1TUB8 0.940 G1TUB8 →
P41098 0.938 P41098 →
Q7T2N5 0.937 Q7T2N5 →
Q7T3M9 0.936 Q7T3M9 →
Q7T3N8 0.936 Q7T3N8 →
P61367 0.936 P61367 →
Q7T3N3 0.936 Q7T3N3 →
Q7T3N6 0.935 Q7T3N6 →
Q90YV2 0.935 Q90YV2 →